Press Releases
Valo Health Appoints Joe Chan as Head of Engineering
Valo to Participate at the BofA Securities 2021 Virtual Tech Solutions for Drug Discovery Conference
Valo to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
Valo Health Announces the Acquisition of Courier Therapeutics
Valo Health to Participate in SVB Leerink CybeRx Conference: Big Data, A.I. & Machine Learning in Healthcare
Valo Health Welcomes Leading Life Sciences and Technology Expert Judy Lewent to Board of Directors
Valo Health and Khosla Ventures Acquisition Co. to Combine and Create Publicly Traded Company Focused on Transforming the Drug Discovery and Development Process
Valo Health to Present at the UBS Global Healthcare Virtual Conference
Valo's CEO to Participate in Financial Times U.S. Pharma and Biotech Summit
Valo Health to Present at the BMO BioPharma Spotlight Series
Valo to Participate in Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence
Valo Health Receives $110 Million in Funding From Koch Disruptive Technologies to Close Series B
Valo Announces Technology & Product Management Expert Nish Lathia as Chief Product Officer
Valo Health to Participate in Barclays and Oppenheimer Healthcare Investor Conferences
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs Details of Initial Therapeutic Programs to be Shared at the 39th J.P. Morgan Healthcare Conference
Valo Announces Exclusive Partnership with G3 the World's Largest and Detailed Cardio-Metabolic Datasets
Valo Health Expands Global Operations With Key Leadership in Tel Aviv
Valo Health Adds Award-Winning Neurobiologist Virginie Buggia-Prevot Ph.D. and Computational Scientist Andrea Rossi Ph.D.
Flagship Pioneering Announces Valo Health to Transform Drug Development
Previous
Next
gg